is tirzepatide a dual agonist and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports Everyone's picking a side. 💛🆚💙

"Theres a real opportunity and need to provide free nutrition guidance and content to educate a growing population of people accessing GLP-1 medications for weight loss so they have long-term, sustainable outcomes." Mike Fisher, CEO, MyFitnessPal Smart devices like wearables and scales that sync with platforms like Apple Health or Google Fit can further simplify tracking

Tirzepatide est autorizado en la UE desde el 11 de diciembre de 2023, as que un mdico colegiado puede recetarlo cuando sea clnicamente adecuado para ti

361: 41729 Lombard KA, Olson AL, Nelson SE, et al

Future regulatory developmentsespecially if the FDA and NIH increase flexibility around novel addiction treatmentscould open additional pathways

Mounjaro (Tirzepatide) and similar medications can increase your resting heart rate and stimulate the sympathetic nervous system